John Overdeck’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-470,344
Closed -$7.9M 3123
2022
Q1
$7.9M Sell
470,344
-198,009
-30% -$3.46M 0.02% 700
2021
Q4
$13.3M Buy
668,353
+280,776
+72% +$5.29M 0.03% 650
2021
Q3
$7.03M Buy
387,577
+352,503
+1,005% +$8.08M 0.02% 978
2021
Q2
$947K Buy
+35,074
New +$981K ﹤0.01% 2515
2021
Q1
Sell
-23,539
Closed -$677K 4371
2020
Q4
$677K Sell
23,539
-96,815
-80% -$2.61M ﹤0.01% 2290
2020
Q3
$2.94M Buy
120,354
+2,372
+2% +$51.2K 0.01% 1083
2020
Q2
$2.11M Sell
117,982
-385,268
-77% -$5.06M 0.01% 1070
2020
Q1
$4.1M Sell
503,250
-359,237
-42% -$4.1M 0.03% 589
2019
Q4
$11.4M Buy
862,487
+626,482
+265% +$7.59M 0.03% 566
2019
Q3
$2.81M Buy
+236,005
New +$4.37M 0.01% 1175

Other funds holding CVET

John Overdeck's CVET Position: Q2 2022 in Review

John Overdeck sold out of Covetrus, Inc. Common Stock (CVET) in Q2 2022, closing a stake of 470,344 shares — an estimated $7.9M sold.

John Overdeck first reported a position in CVET in Q3 2019 and held it in 10 quarters. The position peaked at $13.3M in Q4 2021. 266 funds tracked by Wall St. Rank hold CVET as of Q2 2022.

  • John Overdeck reported no remaining Covetrus, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • John Overdeck sold 470,344 Covetrus, Inc. Common Stock shares in Q2 2022, an estimated $7.9M.
  • John Overdeck first reported a position in Covetrus, Inc. Common Stock in Q3 2019 and held it in 10 quarters.
  • John Overdeck's Covetrus, Inc. Common Stock position peaked at $13.3M in Q4 2021.
  • 266 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q2 2022.

Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.